Arash Mostaghimi

Arash Mostaghimi

Harvard University

H-index: 35

North America-United States

About Arash Mostaghimi

Arash Mostaghimi, With an exceptional h-index of 35 and a recent h-index of 32 (since 2020), a distinguished researcher at Harvard University, specializes in the field of Alopecia Areata, Pyoderma Gangrenosum, Cellulitis, Severe Drug Reactions, Acne.

His recent articles reflect a diverse array of research interests and contributions to the field:

Insurance coverage among the largest insurers per state for laser hair removal in the treatment of hidradenitis suppurativa

The Quest for a More Accurate Diagnosis of Cellulitis: In Dreams Begin Responsibilities

Validation of the Diagnostic Code for Cutaneous Sarcoidosis in an Electronic Health Database: a Cross-sectional Analysis.

Spesolimab use for generalized pustular psoriasis flare prevention in patients with concomitant plaque psoriasis: Results from the Effisayil 2 trial

Measuring GPPGA, Pain, Symptom, and Quality of Life Index Scores in Untreated Generalized Pustular Psoriasis: Results from the Placebo Group of the Effisayil-2 Trial

Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2

Improvement in health‐related quality of life and symptoms of anxiety and depression in patients with alopecia areata randomized to baricitinib or placebo: Results from two …

Characterizing differences in outpatient dermatologic care utilization among disaggregated Asian American subgroups

Arash Mostaghimi Information

University

Position

Brigham & Women's Hospital, Harvard Medical School

Citations(all)

5309

Citations(since 2020)

3924

Cited By

2559

hIndex(all)

35

hIndex(since 2020)

32

i10Index(all)

108

i10Index(since 2020)

97

Email

University Profile Page

Google Scholar

Arash Mostaghimi Skills & Research Interests

Alopecia Areata

Pyoderma Gangrenosum

Cellulitis

Severe Drug Reactions

Acne

Top articles of Arash Mostaghimi

Insurance coverage among the largest insurers per state for laser hair removal in the treatment of hidradenitis suppurativa

Journal of the American Academy of Dermatology

2024/4/1

The Quest for a More Accurate Diagnosis of Cellulitis: In Dreams Begin Responsibilities

JAMA dermatology

2024/3/27

Arash Mostaghimi
Arash Mostaghimi

H-Index: 21

Validation of the Diagnostic Code for Cutaneous Sarcoidosis in an Electronic Health Database: a Cross-sectional Analysis.

The Journal of Investigative Dermatology

2024/3/26

Arash Mostaghimi
Arash Mostaghimi

H-Index: 21

Spesolimab use for generalized pustular psoriasis flare prevention in patients with concomitant plaque psoriasis: Results from the Effisayil 2 trial

SKIN The Journal of Cutaneous Medicine

2024/3/18

Arash Mostaghimi
Arash Mostaghimi

H-Index: 21

Ming Tang
Ming Tang

H-Index: 26

Measuring GPPGA, Pain, Symptom, and Quality of Life Index Scores in Untreated Generalized Pustular Psoriasis: Results from the Placebo Group of the Effisayil-2 Trial

SKIN The Journal of Cutaneous Medicine

2024/3/18

Arash Mostaghimi
Arash Mostaghimi

H-Index: 21

Ming Tang
Ming Tang

H-Index: 26

Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2

Journal of the European Academy of Dermatology and Venereology

2024/3

Improvement in health‐related quality of life and symptoms of anxiety and depression in patients with alopecia areata randomized to baricitinib or placebo: Results from two …

JEADV Clinical Practice

2024/3

Arash Mostaghimi
Arash Mostaghimi

H-Index: 21

Characterizing differences in outpatient dermatologic care utilization among disaggregated Asian American subgroups

Archives of Dermatological Research

2024/3/1

Evaluation of Inclusion and Exclusion Criteria for Pyoderma Gangrenosum in Clinical Research: A Systematic Review

2024/2/12

Arash Mostaghimi
Arash Mostaghimi

H-Index: 21

Subjective assessments in pyoderma gangrenosum diagnostic frameworks undermine framework agreement

International journal of dermatology

2024/2

Afsaneh Alavi
Afsaneh Alavi

H-Index: 27

Arash Mostaghimi
Arash Mostaghimi

H-Index: 21

Estimated Spending on Beremagene Geperpavec for Dystrophic Epidermolysis Bullosa

JAMA dermatology

2024/1/31

Arash Mostaghimi
Arash Mostaghimi

H-Index: 21

Prevalence of pretreatment testing recommended for patients with chronic inflammatory skin diseases

JAMA dermatology

2024/1/31

Richard Wyss
Richard Wyss

H-Index: 12

Arash Mostaghimi
Arash Mostaghimi

H-Index: 21

Comorbid psychiatric disease significantly mediates increased rates of alcohol use disorder among patients with inflammatory and pigmentary skin disorders: a case–control study …

Archives of Dermatological Research

2024/1/22

Mortality and autopsy findings in patients with pyoderma gangrenosum: A multi-institutional series

Dermatology

2024/1/6

Arash Mostaghimi
Arash Mostaghimi

H-Index: 21

Eligibility Criteria for Active Ulcerative Pyoderma Gangrenosum in Clinical Trials: A Delphi Consensus on Behalf of the UPGRADE (Understanding Pyoderma Gangrenosum: Review and …

2023/12/16

Alopecia Areata

Clinical and Basic Immunodermatology

2017

Evaluation of Stigma Toward Individuals With Acne

JAMA dermatology

2024/1/1

Management of Adult Patients With Drug Reaction With Eosinophilia and Systemic Symptoms: A Delphi-Based International Consensus

JAMA dermatology

2024/1/1

Scott Elman
Scott Elman

H-Index: 6

Arash Mostaghimi
Arash Mostaghimi

H-Index: 21

Hundreds of inconsistencies in the nomenclature of pyoderma gangrenosum: The need to harmonise terminology for phenotypes

International Wound Journal

2024/1

Arash Mostaghimi
Arash Mostaghimi

H-Index: 21

Understanding patient perspectives on vaccine decision making in adults with autoimmune bullous diseases: a qualitative study

Archives of Dermatological Research

2024/7

See List of Professors in Arash Mostaghimi University(Harvard University)

Co-Authors

academic-engine